Cargando…
Spotlight on the microbes that produce heat shock protein 90-targeting antibiotics
Heat shock protein 90 (Hsp90) is a promising cancer drug target as a molecular chaperone critical for stabilization and activation of several of the oncoproteins that drive cancer progression. Its actions depend upon its essential ATPase, an activity fortuitously inhibited with a very high degree of...
Autores principales: | Piper, Peter W., Millson, Stefan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603443/ https://www.ncbi.nlm.nih.gov/pubmed/23271830 http://dx.doi.org/10.1098/rsob.120138 |
Ejemplares similares
-
Insights from yeast into whether the rapamycin inhibition of heat shock transcription factor (Hsf1) can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor
por: Millson, Stefan H., et al.
Publicado: (2014) -
Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges
por: Piper, Peter W., et al.
Publicado: (2011) -
Hsp90 and phosphorylation of the Slt2(Mpk1) MAP kinase activation loop are essential for catalytic, but not non-catalytic, Slt2-mediated transcription in yeast
por: Millson, Stefan H., et al.
Publicado: (2022) -
Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma
por: Giubellino, Alessio, et al.
Publicado: (2013) -
Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases
por: Tukaj, Stefan, et al.
Publicado: (2022)